Searched for
PHARMACEUTICALS FDI
Beyond China, beyond tariffs: India, Japan look to MSMEs to turn strategic ties into factory-floor partnershipsAs Japanese Prime Minister Sanae Takaichi visits India, industry sees the biggest opportunity not in tariff concessions but in supplier eco...- Healthium Medtech CEO Anish Bafna steps down, moves to non-executive chairman roleHealthium Medtech's CEO Anish Bafna is transitioning to non-executive chairman as KKR-owned company seeks a new chief within a month. Bafna...
- India’s trade strategy: Moving beyond FTAsCurrently, India’s FTA utilisation rate hovers around 25% compared to 70-80% in developed economies.
- Electronics, pharma and engineering goods lead India's FTA dividend as export engine shifts gearsIndia's electronics sector is poised for significant growth, potentially becoming a manufacturing and export powerhouse. Free Trade Agreeme...
- India's productivity gap with China widens despite strong GDP growth; manufacturing leap still missing: ReportIndia's labour productivity gap with China has widened significantly since 2000, despite strong economic growth. The country has yet to ach...
- India attracted $843 billion in FDI between 2014-15 and 2025-26: OfficialIndia has seen a significant rise in Foreign Direct Investment, attracting USD 843 billion between 2014-15 and 2025-26. Key government init...
- India, Oman trade pact to come into force from June 1; Check what's insideIndia and Oman's Comprehensive Economic Partnership Agreement, CEPA, begins on June 1. This pact offers Indian exports 100% duty-free acces...
- India, Japan discuss steps to fix energy supply disruptionsIndia and Japan are addressing disruptions in energy supply chains and maritime connectivity. External Affairs Minister S Jaishankar met hi...
- From axles to rare earth: India draws up list of 100 products it still can't make enough ofIndia is set to boost its manufacturing sector by identifying around 100 products for domestic production. This initiative aims to reduce r...
- Nifty to hit 42,000 by 2028? New paper that studied market cycles says it's possible if these factors alignA CNI InfoXchange study projects the Nifty could surpass 42,000 by 2028 if sustained foreign investor inflows return. The report highlights...
- Indian investments in US on rise, creating American jobs: OfficialIndian companies are investing significantly in the United States. Recent data shows USD 16.4 billion in foreign direct investment, creatin...
- Indian investments in US on rise, creating American jobs: officialIndian companies have invested USD 16.4 billion in the United States. This investment has created around 70,800 jobs. Indian firms also con...
- Govt has eased FDI norms for foreign cos having small Chinese/Hong Kong stake: An explainerIndia has eased Foreign Direct Investment rules for companies with up to ten percent Chinese or Hong Kong shareholding. These firms can now...
- Nifty’s 2 pillars now facing structural headwinds: Ravi Dharamshi's warning on IT & consumptionHis warning carries weight. ValueQuest has been quietly repositioning for months by moving capital away from consumption-oriented exposures...
- FDI easing for foreign cos with up to 10 pc Chinese stake to be notified soon under FEMAIndia is on the verge of a significant policy alteration, planning to loosen foreign investment regulations for firms that include Chinese ...
- India–New Zealand sign 'once-in-a-generation' FTAIndia and New Zealand signed a “once-in-a-generation” free trade agreement on Monday that gives New Delhi duty-free access to 100% of tarif...
- The K-pop cash flow: South Korean beats power India's FDI remixSouth Korean President Lee Jae Myung's visit to New Delhi signals India's strategic push for large-scale FDI in advanced manufacturing and ...
- Mega FDI plan to focus on faster pharma approvalsThe govt has begun examining ways to shore up foreign investments, including a fast-track mechanism to clear applications of companies espe...
- Government may ease FDI norms in pharmaceutical industryGovt is likely to take a less harsh stand on FDI in pharma to ensure a balance b/w public health concerns & the need to attract investments.
- Prime Minister Manmohan singh likely to take meeting on FDI in pharmaceutical tomorrowNo consensus could emerge in the report of the committee which had senior officials from the ministries of health, industry law finance bes...
Load More
